vTv Therapeutics annual capital expenditures (capex)
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
vTv Therapeutics Capital Expenditures (CapEx) Growth & History (VTVT)
vTv Therapeutics's capital expenditures (capex) was $0 for fiscal 2024.
View full vTv Therapeutics company overviewvTv Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | $0 | $0 | — |
| 2023 | 2023-12-31 | $0 | −$21,000 | — |
| 2022 | 2022-12-31 | $21,000 | $21,000 | — |
| 2021 | 2021-12-31 | $0 | $0 | — |
| 2020 | 2020-12-31 | $0 | −$70,000 | — |
| 2019 | 2019-12-31 | $70,000 | $65,000 | +1300.00% |
| 2018 | 2018-12-31 | $5,000 | −$52,000 | −91.23% |
| 2017 | 2017-12-31 | $57,000 | −$30,000 | −34.48% |
| 2016 | 2016-12-31 | $87,000 | −$17,000 | −16.35% |
| 2015 | 2015-12-31 | $104,000 | $71,000 | +215.15% |
| 2014 | 2014-12-31 | $33,000 | −$148,000 | −81.77% |
| 2013 | 2013-12-31 | $181,000 | — | — |
vTv Therapeutics quarterly capital expenditures (capex)
Q1.15
Q2.15
Q3.15
Q4.15
Q3.16
Q1.17
Q2.17
Q3.17
Q4.17
Q3.21
Q3.22
Q3.23
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q3 2023 | 2023-09-30 | $0 | $0 | — |
| Q3 2022 | 2022-09-30 | $0 | $0 | — |
| Q3 2021 | 2021-09-30 | $0 | — | — |
| Q4 2017 | 2017-12-31 | $18,000 | — | — |
| Q3 2017 | 2017-09-30 | $0 | $0 | — |
| Q2 2017 | 2017-06-30 | $0 | — | — |
| Q1 2017 | 2017-03-31 | $39,000 | — | — |
| Q3 2016 | 2016-09-30 | $0 | −$9,000 | — |
| Q4 2015 | 2015-12-31 | $62,000 | — | — |
| Q3 2015 | 2015-09-30 | $9,000 | — | — |
| Q2 2015 | 2015-06-30 | $29,000 | — | — |
| Q1 2015 | 2015-03-31 | $4,000 | — | — |
vTv Therapeutics capital expenditures (capex) trends
Over the last five fiscal years, vTv Therapeutics's capital expenditures (capex) decreased from $70,000 to $0, a change of −$70,000. The latest reported quarter, Q3 2023, shows $0.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review vTv Therapeutics source filings ↗